Question 1

Who owns RYIS?

Accepted Answer

SUNESIS PHARMACEUTICALS INCORPORATED COM NEW (RYIS) is held by institutional investors who disclose positions via SEC 13F filings. View the full list of institutional holders on HoldingsIntel.

Question 2

Are institutions buying or selling RYIS?

Accepted Answer

HoldingsIntel tracks quarter-over-quarter changes in institutional positions for SUNESIS PHARMACEUTICALS INCORPORATED COM NEW, showing new buyers, position increases, decreases, and exits with conviction-weighted sentiment.

Question 3

What is the Smart Money Verdict on RYIS?

Accepted Answer

The Smart Money Verdict combines four independent signals (institutional 13F activity, insider trades, activist filings, and congressional trades) into a single assessment for SUNESIS PHARMACEUTICALS INCORPORATED COM NEW.

Question 4

Is institutional money flowing into RYIS?

Accepted Answer

0 institutional investors hold SUNESIS PHARMACEUTICALS INCORPORATED COM NEW (RYIS). View detailed buyer/seller breakdown on HoldingsIntel.

Question 5

What do hedge funds think about RYIS?

Accepted Answer

Track institutional sentiment and conviction scores for SUNESIS PHARMACEUTICALS INCORPORATED COM NEW (RYIS) including Smart Money Verdict and position changes on HoldingsIntel.

Fund	Action	Shares	Value	Weight	Est. P&L
GEODE CAPITAL MANAGEMENT, LLC	Exited	0(-100.0%)	$166,000	0.0%	—
NORTHERN TRUST CORP	Exited	0(-100.0%)	$57,000	0.0%	—
CITADEL ADVISORS LLC	Exited	0(-100.0%)	$62,000	0.0%	—
UBS Group AG	Exited	0(-100.0%)	$9,000	0.0%	—
BAKER BROS. ADVISORS LP	Exited	0(-100.0%)	$106,000	0.0%	—

SUNESIS PHARMACEUTICALS INCORPORATED COM NEW

Continue exploring